Major challenges in pharmaceutical innovation include diminishing returns in R&D investment from top-tier companies. The infographic below illustrates some of the factors leading to increasing costs of launching new products in a highly regulated environment.
Deloitte UK Centre for Health Solutions presents the Measuring the return from Pharmaceutical innovation 2013